key: cord-0850510-1kf1939z
authors: CRESPY, Valentin; BENZENINE, Eric; MARIET, Anne-Sophie; BAUDRY, Anna; BERNARD, Chloe; BEJOT, Yannick; GIROUD, Maurice; STEINMETZ, Eric; QUANTIN, Catherine
title: Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France
date: 2021-12-15
journal: J Vasc Surg
DOI: 10.1016/j.jvs.2021.11.064
sha: 09b9b20953461b929ada2830dcd3a4a2cfb64b21
doc_id: 850510
cord_uid: 1kf1939z

OBJECTIVE: The aim of this study was to evaluate the impact of the COVID-19 pandemic on the trends of carotid revascularization (endarterectomy (CEA), transfemoral stenting (TFCAS)) for symptomatic and asymptomatic carotid stenosis before, during and after the end of the first lockdown in 2020 in France. METHODS: Nationwide data were provided by the French National Hospital Discharge database (Programme de Médicalisation des Systèmes d’Information). We retrospectively analyzed patients admitted for CEA or TFCAS in all French public and private hospitals during a nine-month period (January-September) in 2017, 2018, 2019 and 2020. Procedures were identified using the French Common Classification of Medical Procedures. Stenoses were considered symptomatic in the presence of stroke and/or transient ischemic attack codes (according to the International Classification of Diseases-Tenth Revision) during the stay, and asymptomatic in the absence of these codes. Hospitalization rates in 2020 were compared with the rates in the same period in the three previous years. RESULTS: Between January and September 2020, 12 546 patients were hospitalized for carotid artery surgery (CEA and TFCAS) in France. Compared with the three previous years, there was a decline in hospitalization rates for asymptomatic (-68.9%) and symptomatic (-12.6%) CEA procedures in April, starting at the pandemic peak concomitant with the first national lockdown. This decrease was significant for asymptomatic CEA (p<0.001). After the lockdown, while CEA for asymptomatic stenosis returned to usual activity, CEA for symptomatic stenosis presented a significant rebound, up 18.52% in August compared with previous years. Lockdown also had consequences on TFCAS procedures, with fewer interventions for both asymptomatic (-60.53%) and symptomatic stenosis (-16.67%) in April. CONCLUSIONS: This study demonstrates a severe drop for all interventions during the first peak of the COVID-19 pandemic in France. However, the trends in the post-lockdown period were different for the various procedures. These data can be used to anticipate future decisions and organization for cardiovascular care.

In this French nationwide retrospective cohort study, surgical interventions for symptomatic and 13 asymptomatic carotid stenosis decreased by up to 58% during the peak of the COVID-19 14 pandemic, with no rebound after the first lockdown, except for symptomatic carotid stenosis International Classification of Diseases-Tenth Revision) during the stay, and asymptomatic in the 12 absence of these codes. Hospitalization rates in 2020 were compared with the rates in the same 13 period in the three previous years.

14 Results: Between January and September 2020, 12 546 patients were hospitalized for carotid 15 artery surgery (CEA and TFCAS) in France. Compared with the three previous years, there was 16 a decline in hospitalization rates for asymptomatic (-68.9%) and symptomatic (-12.6%) CEA 17 procedures in April, starting at the pandemic peak concomitant with the first national lockdown. 18 This decrease was significant for asymptomatic CEA (p<0.001). After the lockdown, while CEA 19 for asymptomatic stenosis returned to usual activity, CEA for symptomatic stenosis presented a 20 significant rebound, up 18.52% in August compared with previous years. Lockdown also had Introduction 1 Since the beginning of the COVID-19 pandemic, there have been huge changes in medical and 2 surgical care, particularly during the first lockdown in 2020. In practice, the lockdown was 3 required to prevent viral transmission and to maintain the ability of healthcare centers to manage 4 COVID-19 and non-COVID-19 emergencies 1 . Several reports have underlined a decrease in the 5 rate of hospital admissions for medical emergencies such as myocardial infarction [2] [3] [4] [5] or stroke 6,7 , 6 but the impact of the lockdown on the management of peripheral vascular diseases such as 7 carotid stenosis still needs to be assessed. Carotid stenosis is considered to be responsible for 10 8 to 15% of ischemic strokes 8 . These strokes may be prevented by carotid endarterectomy (CEA) 9 or transfemoral carotid artery stenting (TFCAS). In current guidelines, CEA for symptomatic 10 stenosis must be performed within 14 days after symptom onset to decrease the risk of recurrent 11 strokes and transient ischemic attacks (TIA), for which the risk in this period is up to 25% 9-11 . 12 Assessing the repercussions of the COVID-19 pandemic on carotid revascularization, while 13 differentiating CEA/TFCAS for asymptomatic and for symptomatic plaques, may help the 14 national healthcare system deal with such crises in the future.

The aim of this study was to evaluate the impact of the COVID-19 pandemic on the volume of 16 CEA and TFCAS for symptomatic and asymptomatic carotid stenosis, observed before and 17 during the first lockdown in 2020 in France. This analysis used complete nationwide 18 administrative data from all primary and comprehensive hospitals, and compared the data from 19 2020 with the same time period in the three previous years. The second objective was to evaluate The nationwide data of this retrospective cohort study were provided by the French National and asymptomatic in the absence of these codes. A sensitivity analysis was performed in which 21 symptomatic stenosis was defined as the presence of an IS or TIA coded as primary diagnosis on 22 J o u r n a l P r e -p r o o f 8 the first unit of the carotid revascularization intervention stay or coded in previous stays in the 60 1 days before the stay for carotid revascularization. 2 COVID-19 was identified using specific codes created by the ATIH for this pandemic. The 3 codes were considered as a primary diagnosis but also as associated and secondary diagnoses.

This ensured that the four diseases were identified even if another severe disease was the primary 5 diagnosis.

Other variables were extracted: age in 4 classes (< 65, 65-79, 80-84, ≥ 85 years), sex, and 7 available cerebro-cardiovascular risk factors (hypertension, diabetes mellitus, obesity, atrial 8 fibrillation (AF)), chronic renal failure, coronary artery disease, chronic obstructive pulmonary 9 disease (COPD), chronic respiratory failure, and in-hospital death.

Study design 12 We retrospectively analyzed all patients admitted to primary or comprehensive public and 13 private French hospitals for CEA and/or TFCAS between January 1 and September 30, 2020, This retrospective study had no impact on patient care and all data were anonymous. This study 5 was authorized by the French Data Protection Authority on July 3, 2020 (Registration number: 6 DR-2020-250 on 07/03/2020) and therefore was conducted in accordance with the Declaration of 7 Helsinki. Written consent was not needed for this study. Table 1 , online only). In the 2020 national lockdown period (weeks 12 to 19), the 5 decrease in the number of surgical interventions was parallel to the peak of the pandemic in 6 France ( Figure 1 ). This decline started during week 9 (3 weeks before the beginning of 7 lockdown), and continued until April, decreasing 58.4% compared to the mean of the previous 8 years. A rebound occurred very quickly in April, and by June there was a complete recovery 9 compared with prior years (Figure 1 , Table 1 ).

The same trends were observed in the total CEA group (Figure 2 Table 1 ). However, 12 in the symptomatic CEA subgroup, there was a particular trend; after the initial drop in 13 interventions (-12.5% and -12.94% in March and April, respectively), there was a rapid increase 14 in cases that started during lockdown and that went on to exceed the values of the previous years 15 in the following months (18.5% more interventions in August, and 10.03% more in September). 16 After the end of lockdown, from May to September, CEA for symptomatic stenosis remained Table 1 ).

Using interrupted time series for 2020, we observed a significant decrease in the level of CEA 19 overall and for asymptomatic stenosis during lockdown compared with the period before 20 lockdown, and there was a significant increase after lockdown compared with during lockdown 21 (p<0.001 for all) (Supplemental Figure 1 ). For CEA for symptomatic stenosis, we observed a Similar trends emerged for all TFCAS procedures and for those performed for asymptomatic 1 stenosis. In total, a mean of 903 TFCAS procedures were performed between 2017 and 2019, 2 compared with 858 in 2020, totalling a drop of 4.8% (Table 1) . There was a decrease in the 3 volume of surgical interventions starting before lockdown in both asymptomatic and 4 symptomatic groups, followed by a fast recovery to usual activity levels during lockdown, and an (Table 1) .

Using interrupted time series for 2020, we observed a significant decreasing slope for TFCAS 9 for all patients and for asymptomatic stenosis before lockdown (p=0.030 and 0.024, 10 respectively), and a significant increase after lockdown compared with during (p=0.0094 and 11 0.015, respectively) (Supplemental Figure 1 ).

Hospitalizations for IS or TIA decreased during the lockdown and then returned to the usual 13 numbers after the lockdown (Supplemental Table 2 ).

14 The sensitivity analysis on the definition of symptomatic stenosis led to similar results.

The clinical characteristics of patients treated with CEA and TFCAS are presented in Table 2 16 and 3, respectively. In-hospital death was similar in both groups. During the study period, 5 17 patients in the asymptomatic CEA group underwent surgery while suffering from COVID-19 18 (0.6%) compared with 12 patients in the symptomatic group (2.8%). Only one patient with 19 COVID-19, who had symptomatic stenosis, underwent stenting treatment. In the TFCAS 20 subgroups, there were no significant differences in age, sex, hypertension, diabetes, obesity,

This nationwide population-based study revealed a deep drop in activity for overall carotid 2 procedures (CEA+TFCAS) parallel to the peak of the first wave of the COVID-19 pandemic, 3 which was not compensated for after lockdown. In the analyses focused on CEA patients, 4 asymptomatic procedures showed the same trend. However, for symptomatic stenosis, CEA 5 numbers dropped around the peak of the first wave, but afterwards we observed a rebound 6 exceeding the usual activity in prior years. Moreover, patients with postponed CEA did not 7 receive TFCAS instead. In symptomatic stenosis, the same decrease in CEA rates was observed in the month following 10 the peak of the first wave. In France, we observed an initial phase of decline in the symptomatic 11 population for several potential reasons such as hospital adjustments to the pandemic (same as were operated on at a later stage, possibly beyond the study period. Nevertheless, these data 7 suggest that many patients with asymptomatic stenosis did not receive an early intervention in 8 the weeks after the lockdown. On the other hand, elective TFCAS interventions were maintained 9 during the immediate post-lockdown period. Afterwards, we observed a decrease in TFCAS 10 interventions during the summer, but the number was still higher than in previous years. For 11 some patients, as suggested previously, TFCAS may have been offered instead of CEA so that 12 local anesthesia could be used rather than cervical blockade or general anesthesia, which may 13 have been unavailable. suggesting that these patients could be adequately managed without carotid revascularization 18 procedure. Although this issue remains to be clarified with ongoing trials, patients whose 19 procedures are postponed should benefit from optimal medical treatment and be followed up The present study has several strengths. While the collection of administrative data may be 6 hindered by a delay in data collection, but we have follow-up for data collection until December 7 2020, reinforcing the reliability of the data collected in the 4 months after lockdown. All French 8 primary and comprehensive public and private hospital data were included, and our data was 9 thus nationally representative. In addition, though it has been well documented in other countries 10 that carotid stenosis procedures tended to decrease in the years preceding the COVID-19 11 pandemic 29-31 , our data from the pandemic period in 2020 are compared with the mean from the In this nationwide study, we report a 58% drop in carotid revascularization procedures during the 2 first lockdown in France, which was mostly due to a drop in asymptomatic procedures. For Figure 1 . Observed (Obs) and predicted (ITS) hospitalizations for carotid revascularization intervention for weeks 2 to 39 of 2020 in France, interrupted time series (ITS) analysis with three periods (before, during, after the first lockdown)

Impact of the COVID-19 Pandemic on Emergency Department Visits -United States

Hospital admissions 6 for acute myocardial infarction before and after lockdown according to regional 7 prevalence of COVID-19 and patient profile in France: a registry study

Monitoring indirect 10 impact of COVID-19 pandemic on services for cardiovascular diseases in the UK

COVID-19 13 pandemic and admission rates for and management of acute coronary syndromes in 14

Fewer 16 Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic

Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, 20 and After the National Lockdown

Supplemental Table 1. Monthly hospitalizations for CEA and TFCAS in France from

 February  1415  1392  245  243  1169  1149  March  1626  1168  270  242  1356  926  April  1487  610  262  229  1225  381  May  1403  1150  259  287  1144  863  June  1609  1605  260  281  1348  1324  July  1487  1392  267  271  1220  1121  August  1008  1108  224  274  783  834  September  1488  1609  239  262  1248  1347  Total  13007  11688  2273  2328  10730  9360  Transfemoral Carotid Artery Stenting  (TFCAS)  January  105  122  21  27  84  95  February  95  112  24  25  70  87  March  112  70  26  17  85  53  April  101  50  24  20  76  30  May  101  62  20  19  81  43  June  118  129  29  29  89  100  July  105  93  24  25  81  68  August  60  107  18  23  42  84  September  106  113  21  27  85  86  Total  903  858  207  212 Figure 1 . Observed (Obs) and predicted (ITS) hospitalizations for carotid revascularization intervention for weeks 2 to 39 of 2020 in France, interrupted time series (ITS) analysis with three periods (before, during, after the first lockdown)